Categories AlphaGraphs, Earnings, Health Care

Key highlights from CVS Health (CVS) Q2 2020 earnings results

CVS Health Corporation (NYSE: CVS) reported second quarter 2020 earnings results today.

Total revenues increased 3% to $65.3 billion, driven by growth across all segments.

The COVID-19 pandemic negatively affected results in the Pharmacy Services and Retail/LTC segments as new therapy prescriptions dropped due to lower provider visits.

Net income grew 54.6% to $2.9 billion, or $2.26 per share. Adjusted EPS totaled $2.64.

CVS raised its GAAP EPS guidance range to $5.59-5.72 from $5.47-5.60 and adjusted EPS guidance range to $7.14-7.27 from $7.04-7.17.

Past Performance

CVS Health reports Q1 2020 earnings results
CVS health Q4 2019 earnings infographic

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

CCL Earnings: Carnival Corp. Q4 2024 revenue rises 10%

Carnival Corporation & plc. (NYSE: CCL) Friday reported strong revenue growth for the fourth quarter of 2024. The cruise line operator reported a profit for Q4, compared to a loss

Key metrics from Nike’s (NKE) Q2 2025 earnings results

NIKE, Inc. (NYSE: NKE) reported total revenues of $12.4 billion for the second quarter of 2025, down 8% on a reported basis and down 9% on a currency-neutral basis. Net

FDX Earnings: FedEx Q2 2025 adjusted profit increases; revenue dips

Cargo giant FedEx Corporation (NYSE: FDX), which completed an organizational restructuring recently, announced financial results for the second quarter of 2025. Second-quarter earnings, excluding one-off items, were $4.05 per share,

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top